BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 31666108)

  • 21. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
    Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C
    Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway.
    Gao Q; Cheng B; Chen C; Lei C; Lin X; Nie D; Li J; Huang L; Li X; Wang K; Huang A; Tang N
    Clin Transl Med; 2022 Aug; 12(8):e995. PubMed ID: 35979621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2/ARE/HO-1, PPARγ and TGF-β1/Smad3 signaling, and amelioration of oxidative stress and inflammation.
    Mahmoud AM; Mohammed HM; Khadrawy SM; Galaly SR
    Chem Biol Interact; 2017 Nov; 277():146-158. PubMed ID: 28935427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ptgr1 expression is regulated by NRF2 in rat hepatocarcinogenesis and promotes cell proliferation and resistance to oxidative stress.
    Sánchez-Rodríguez R; Torres-Mena JE; Quintanar-Jurado V; Chagoya-Hazas V; Rojas Del Castillo E; Del Pozo Yauner L; Villa-Treviño S; Pérez-Carreón JI
    Free Radic Biol Med; 2017 Jan; 102():87-99. PubMed ID: 27867096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
    Lu Y; Zhou J; Zhang J; Wang Z; Yu Y; Miao M; Yao Q
    Biomed Pharmacother; 2019 Dec; 120():109532. PubMed ID: 31605953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
    Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
    J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
    Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
    Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
    Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R
    Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the Nrf2 response by oleanolic acid oxime morpholide (3-hydroxyiminoolean-12-en-28-oic acid morpholide) is associated with its ability to induce apoptosis and inhibit proliferation in HepG2 hepatoma cells.
    Narożna M; Krajka-Kuźniak V; Kleszcz R; Bednarczyk-Cwynar B; Szaefer H; Baer-Dubowska W
    Eur J Pharmacol; 2020 Sep; 883():173307. PubMed ID: 32668287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
    Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
    BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141.
    Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L
    Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
    Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
    Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Black currant anthocyanins abrogate oxidative stress through Nrf2- mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma.
    Thoppil RJ; Bhatia D; Barnes KF; Haznagy-Radnai E; Hohmann J; Darvesh AS; Bishayee A
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1244-57. PubMed ID: 22873220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.
    Tian B; Lu ZN; Guo XL
    Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
    Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
    Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
    Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis.
    Ikeda H; Nishi S; Sakai M
    Biochem J; 2004 Jun; 380(Pt 2):515-21. PubMed ID: 14960151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
    Kakehashi A; Ishii N; Sugihara E; Gi M; Saya H; Wanibuchi H
    Cancer Sci; 2016 May; 107(5):609-18. PubMed ID: 26882440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
    Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
    Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.